Haemophilus Influenzae Type Infection
📧 Sign up to get email alerts when something new happens for Haemophilus Influenzae Type Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine [Phase 3]
A Phase 3 trial comparing the DTaP-HB-PRP-T combined vaccine to Tritanrix-HepB/Hib, both given concomitantly with oral polio vaccine; result…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Safety of Hib Vaccine (Bio Farma) [Phase 1]
A Phase 1 study evaluating the safety of Bio Farma's Haemophilus influenzae type b vaccine in healthy participants has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants [Phase 3]
Phase 3 trial comparing DTaP-HB-PRP~T with Tritanrix HepB/Hib, administered concomitantly with OPV in healthy infants; results have been pos…
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers [Phase 2]
A Phase 2 multicenter open-label study to assess the immunogenicity of an investigational Hib vaccine (NU300) in toddlers.
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants [Phase 3]
A Phase 3 trial assessed lot-to-lot consistency and immunogenicity of three lots of GlaxoSmithKline's Hib conjugate vaccine compared with Ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ [Phase 3]
Phase 3 study evaluating a combined DTaP-IPV-HepB-PRP-T vaccine given after a primary series of DTaP-IPV-HepB-PRP-T or Infanrix Hexa; result…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination [Phase 4]
Phase 4 study evaluating whether Quinvaxem can be interchanged with other pentavalent vaccines during routine childhood vaccinations; the tr…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. [Phase 3]
Phase 3 safety-focused trial comparing the DTaP-IPV-Hep B-PRP~T vaccine to Tritanrix-HepB/Hib and OPV when given at 2, 4, and 6 months.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines [Phase 2]
Phase 2 clinical trial update evaluating Hib-MenCY-TT vaccine compared with licensed Hib and meningococcal serogroup C vaccines; study compl…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB [Phase 3]
Phase 3 trial assessing long-term antibody persistence at 1, 3, and 5 years after a fourth Hib-MenCY-TT dose, compared with ActHIB.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age [Phase 3]
A Phase 3 trial comparing Hib-MenCY-TT with a licensed Haemophilus influenzae type b conjugate vaccine in infants shows safety data; the stu…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Pentaxim given as three-dose primary vaccination with an 18-month booster.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines [Phase 4]
Phase 4 clinical trial assessing immunogenicity and safety of PENTAXIM vaccine in the Philippines for diphtheria, tetanus, poliomyelitis, pe…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]
Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Sanofi Pasteur Pentaxim combined vaccine in infants in Thailand; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b [Phase 1]
Phase 1 trial assessing safety and reactogenicity of a monovalent Haemophilus influenzae type b conjugate vaccine. The study sponsored by No…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and lot-to-lot comparability of the DTaP vaccine DAPTACEL when administered with other reco…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China [Phase 3]
Phase 3 clinical trial in infants in China compared two Haemophilus influenzae type b vaccines (monovalent CRM197-conjugated vs tetanus toxo…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants [Phase 3]
Phase 3 study evaluating immunogenicity and safety of a booster dose of monovalent glycoprotein-conjugated Hib vaccine in healthy infants ag…
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of a monovalent Haemophilus influenzae type b conjugate vaccine has completed. The sponso…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China [Phase 3]
A Phase 3 clinical trial in toddlers compared booster doses of Vaxem Hib and Hiberix to prevent Haemophilus influenzae type b infection in C…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC [Phase 3]
This Phase 3 long-term persistence study evaluated a booster dose of GSK's Hib-MenC conjugate vaccine. The trial results were completed and …
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study [Phase 3]
Immunogenicity and safety data for the fourth dose of LBVH0101 in LG Life Sciences' LG-VHCL002 Phase 3 Hib vaccine study.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Retrospective Survey of Safety of Fourth Dose Pentacel® in Children
A completed clinical trial update reporting safety results from a retrospective survey of a fourth dose of Pentacel in children.
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ [Phase 3]
Phase 3 study evaluating whether Pneumococcal Conjugate Vaccine (PCV) affects the immunogenicity of Pentacel; results were completed and pos…